HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An intracameral approach for recalcitrant fungal keratitis.

AbstractPURPOSE:
To describe 2 cases of recalcitrant fungal keratitis successfully treated with intracameral Amphotericin B.
METHODS:
Interventional case series.
RESULTS:
A 59-year-old female and a 41-year-old male each presented with fungal keratitis, caused by Bipolaris spp. and Fusarium spp. respectively. Both cases were unresponsive to topical antifungals, causing persistent discomfort and decreased vision. The two patients subsequently received a single dose of intracameral amphotericin B (ICAMB) 10mcg/0.1 mL, in addition to continued topical natamycin. Both patients had remarkable results following ICAMB, with best corrected visual acuity of 20/20 and full corneal reepithelization following treatment.
CONCLUSIONS:
We report 2 cases of intractable fungal keratitis that benefited from intracameral injections of amphotericin B. This route of delivery appears to be very effective because the medication is delivered directly to the deeper layers of the cornea, where fungal infections tend to reside, and where topical and systemic routes have difficulty accessing.
AuthorsLibing K Dong, David B Krebs
JournalAmerican journal of ophthalmology case reports (Am J Ophthalmol Case Rep) Vol. 25 Pg. 101369 (Mar 2022) ISSN: 2451-9936 [Electronic] United States
PMID35146213 (Publication Type: Case Reports)
Copyright© 2022 The Authors. Published by Elsevier Inc.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: